154 related articles for article (PubMed ID: 17229056)
1. Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist.
Kjalke M; Kjellev S; Rojkjaer R
J Thromb Haemost; 2007 Apr; 5(4):774-80. PubMed ID: 17229056
[TBL] [Abstract][Full Text] [Related]
2. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count.
Lisman T; Adelmeijer J; Cauwenberghs S; Van Pampus EC; Heemskerk JW; De Groot PG
J Thromb Haemost; 2005 Apr; 3(4):742-51. PubMed ID: 15842358
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generation.
Lisman T; Adelmeijer J; Heijnen HF; de Groot PG
Blood; 2004 Mar; 103(5):1720-7. PubMed ID: 14592825
[TBL] [Abstract][Full Text] [Related]
4. The in vitro effect of recombinant factor VIIa on coated platelet formation and clot dynamics of stored platelet concentrates.
Svendsen MS; Kristensen AT; Bochsen L; Salado-Jimena JA; Johansson PI
Transfusion; 2009 Oct; 49(10):2186-94. PubMed ID: 19527478
[TBL] [Abstract][Full Text] [Related]
5. Influence of cardiopulmonary bypass on the interaction of recombinant factor VIIa with activated platelets.
Kjalke M; Runge M; Rojkjaer R; Steinbruchel D; Johansson PI
J Extra Corpor Technol; 2009 Jun; 41(2):97-104. PubMed ID: 19681308
[TBL] [Abstract][Full Text] [Related]
6. Development of a flow cytometric assay for detection of coated platelets in dogs and evaluation of binding of coated platelets to recombinant human coagulation factor VIIa.
Knudsen T; Kjalke M; Tranholm M; Nichols TC; Jensen AL; Kristensen AT
Am J Vet Res; 2011 Aug; 72(8):1007-14. PubMed ID: 21801056
[TBL] [Abstract][Full Text] [Related]
7. Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation.
Lisman T; Moschatsis S; Adelmeijer J; Nieuwenhuis HK; De Groot PG
Blood; 2003 Mar; 101(5):1864-70. PubMed ID: 12411291
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms.
Keshava S; Pendurthi UR; Esmon CT; Rao LVM
J Thromb Haemost; 2020 Aug; 18(8):1911-1921. PubMed ID: 32359012
[TBL] [Abstract][Full Text] [Related]
9. The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface.
Weeterings C; de Groot PG; Adelmeijer J; Lisman T
Blood; 2008 Oct; 112(8):3227-33. PubMed ID: 18612104
[TBL] [Abstract][Full Text] [Related]
10. Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A.
Lisman T; de Groot PG; Lambert T; Røjkjaer R; Persson E
J Thromb Haemost; 2003 Oct; 1(10):2175-8. PubMed ID: 14521601
[TBL] [Abstract][Full Text] [Related]
11. The interaction of recombinant factor VIIa with platelet glycoprotein Ib.
Lisman T; de Groot PG
Thromb Res; 2010 Apr; 125 Suppl 1():S13-5. PubMed ID: 20153024
[TBL] [Abstract][Full Text] [Related]
12. Recombinant factor VIIa addition to haemophilic blood perfused over collagen/tissue factor can sufficiently bypass the factor IXa/VIIIa defect to rescue fibrin generation.
Li R; Panckeri KA; Fogarty PF; Cuker A; Diamond SL
Haemophilia; 2017 Sep; 23(5):759-768. PubMed ID: 28475272
[TBL] [Abstract][Full Text] [Related]
13. Factor VIIa-mediated tenase function on activated platelets under flow.
Goel MS; Diamond SL
J Thromb Haemost; 2004 Aug; 2(8):1402-10. PubMed ID: 15304047
[TBL] [Abstract][Full Text] [Related]
14. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
15. Activation of platelets in whole blood by recombinant factor VIIa by a thrombin-dependent mechanism.
Wilbourn B; Harrison P; Mackie IJ; Liesner R; Machin SJ
Br J Haematol; 2003 Aug; 122(4):651-61. PubMed ID: 12899721
[TBL] [Abstract][Full Text] [Related]
16. A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation.
Campbell RA; Fischer TH; Wolberg AS
Br J Haematol; 2007 Jul; 138(1):82-93. PubMed ID: 17555451
[TBL] [Abstract][Full Text] [Related]
17. High-Dose Epinephrine Enhances Platelet Aggregation at the Expense of Procoagulant Activity.
Aliotta A; Bertaggia Calderara D; Zermatten MG; Alberio L
Thromb Haemost; 2021 Oct; 121(10):1337-1344. PubMed ID: 33690868
[TBL] [Abstract][Full Text] [Related]
18. A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia.
Allen GA; Persson E; Campbell RA; Ezban M; Hedner U; Wolberg AS
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):683-9. PubMed ID: 17204663
[TBL] [Abstract][Full Text] [Related]
19. Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood.
Gerotziafas GT; Depasse F; Chakroun T; Samama MM; Elalamy I
Thromb Haemost; 2004 Mar; 91(3):531-7. PubMed ID: 14983229
[TBL] [Abstract][Full Text] [Related]
20. General haemostatic agents--fact or fiction?
Hedner U
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
